# Bevacizumab and Carboplatin for Patients With Ovarian Cancer

> **NCT00744718** · PHASE2 · COMPLETED · sponsor: **Vejle Hospital** · enrollment: 73 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00744718
- **Lead sponsor:** Vejle Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2015-08
- **Final completion:** 2015-12
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2016-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00744718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00744718, "Bevacizumab and Carboplatin for Patients With Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00744718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*